Dren Bio
Industry · 5 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas Triple Negative Breast Cancer, HER2-negative Breast Cancer, Non Small Cell Lung Cancer | Phase 1 | 2025-06-03 |
| Completed | A Study of Subcutaneous DR-01 in Healthy Volunteers Healthy Volunteer | Phase 1 | 2025-03-03 |
| Recruiting | A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo Alopecia Areata, Vitiligo | Phase 1 | 2024-10-30 |
| Completed | A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DR-0201 in Healthy Adult Vo Healthy Adult Volunteers | Phase 1 | 2023-11-26 |
| Recruiting | A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous Gamma-Delta T-Cell Lymphoma, Primary Cutaneous CD8+ Aggressive Epidermotropic T-Cell Lymphoma | Phase 1 / Phase 2 | 2022-07-13 |